GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (CHIX:CURNz) » Definitions » Other Current Payables

Curatis Holding AG (CHIX:CURNZ) Other Current Payables : CHF0.00 Mil (As of Jun. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Curatis Holding AG Other Current Payables?

Curatis Holding AG's Other Current Payables for the quarter that ended in Jun. 2024 was CHF0.00 Mil.

Curatis Holding AG's quarterly Other Current Payables declined from Jun. 2023 (CHF0.04 Mil) to Dec. 2023 (CHF0.00 Mil) but then stayed the same from Dec. 2023 (CHF0.00 Mil) to Jun. 2024 (CHF0.00 Mil).

Curatis Holding AG's annual Other Current Payables increased from Dec. 2021 (CHF0.00 Mil) to Dec. 2022 (CHF0.04 Mil) but then declined from Dec. 2022 (CHF0.04 Mil) to Dec. 2023 (CHF0.00 Mil).


Curatis Holding AG Other Current Payables Historical Data

The historical data trend for Curatis Holding AG's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curatis Holding AG Other Current Payables Chart

Curatis Holding AG Annual Data
Trend Dec21 Dec22 Dec23
Other Current Payables
- 0.04 -

Curatis Holding AG Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Current Payables Get a 7-Day Free Trial 0.07 0.04 0.04 - -

Curatis Holding AG Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Curatis Holding AG Other Current Payables Related Terms

Thank you for viewing the detailed overview of Curatis Holding AG's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Curatis Holding AG Business Description

Traded in Other Exchanges
Address
Weierweg 7, Liestal, CHE, CH-4410
Curatis Holding AG is a specialty pharmaceutical company based in Switzerland. It focus on the acquisition, development and commercialisation of medicines for the prevention, diagnosis and treatment of rare and specialty care diseases. Curatis is engaged in two business areas: Distribution business for orphan disease and specialty care medicines and Development business for orphan and specialty care disease medicines. Its product include Aggrastat (Tirofiban), AmbiFul (Fulvestrant), Brinavess (Vernakalant), Coldistop, Cuprior (Trientin), Cyanokit (Hydroxocobalamin), etc.

Curatis Holding AG Headlines

No Headlines